Ulrike Verzetnitsche has been appointed to the newly created position of chief technical officer at the cell therapy company apceth GmbH & Co KG to help expand the company’s fee-for-service GMP manufacturing business and oversee other production. apceth has a clinical-stage stem cell product for cancer. Ms Verzetnitsch was previously head of production at a German unit of Takeda Pharmaceutical Company Ltd, and before that director of production at Baxter. She holds a Master’s Degree in chemical engineering from the Technical University in Vienna, Austria.
apceth announced the appointment on 23 April 2015.
Copyright 2015 Evernow Publishing Ltd